Hypothyroidism/subclinical hypothyroidism and metabolic dysfunction-associated steatotic liver disease: advances in mechanism and treatment

Hypothyroidism/subclinical hypothyroidism and metabolic dysfunction-associated steatotic liver disease: advances in mechanism and treatment

Abstract Hypothyroidism is a risk factor for metabolic dysfunction-associated steatotic liver disease (MASLD) but it is not clear whether subclinical hypothyroidism (SCH) increases the risk of MASLD and whether SCH patients with MASLD require treatment. In this study, we reviewed articles published...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Sicheng Pu, Binbin Zhao, Yuxuan Jiang, Xuejiao Cui
Materialtyp: Artikel
Språk:English
Publicerad: BMC 2025-02-01
Serie:Lipids in Health and Disease
Ämnen:
Hypothyroidism
Subclinical hypothyroidism
Non-alcoholic fatty liver disease
Metabolic dysfunction-associated steatotic liver disease
Molecular roles
Thyroid-related medication
Länkar:https://doi.org/10.1186/s12944-025-02474-0

Liknande verk

Liknande verk